{"brief_title": "Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)", "brief_summary": "The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine.", "condition": ["Migraine"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["MK0462, rizatriptan benzoate / Duration of Treatment: 1day", "Comparator: placebo / Duration of Treatment: 1 day"], "criteria": "Inclusion Criteria: - Six month history of migraine; attacks typically mild when they begin with 1-4 migraine attacks per month. Exclusion Criteria: - Heart disease - High blood pressure", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Migraine Disorders", "Rizatriptan"], "id": "NCT00095004"}